Cantor Fitzgerald Initiates Coverage of AVITA Medical (RCEL) with Overweight Recommendation
Fintel reports that on June 27, 2023, Cantor Fitzgerald initiated coverage of AVITA Medical (NASDAQ:RCEL) with a Overweight recommendation. Analyst Price Forecast Suggests 37.00% Upside As of June 2, 2023, the average one-year price target for AVITA Medical is 21.52. The forecasts range from a low of 18.18 to a…
bubmagJune 27, 2023